Ryo Naito, MD, MSc, PhD; Katsumi Miyauchi, MD, PhD; Satoshi Yasuda, MD, PhD; et al.
free access
JAMA Cardiol. 2022;7(8):787-794. doi:10.1001/jamacardio.2022.1561
This post hoc secondary analysis of the AFIRE randomized clinical trial investigates if rivaroxaban monotherapy is associated with a lower incidence of cardiovascular/bleeding events than combination anticoagulant and antiplatelet therapy in patients with atrial fibrillation and stable coronary artery disease.
-
Invited Commentary
Antithrombotic Therapy in Atrial Fibrillation and Coronary Artery Disease: Does Less Mean More?
Ying X. Gue, MBChB, PhD; Diana A. Gorog, MBBS, MD, PhD; Gregory Y. H. Lip, MD
JAMA Cardiol
Sidong Li, BM; Scott A. Lear, PhD; Sumathy Rangarajan, MSc; et al.
free access
JAMA Cardiol. 2022;7(8):796-807. doi:10.1001/jamacardio.2022.1581
This cohort study investigates the association between daily sitting time and mortality and cardiovascular disease in countries of different economic levels.
Daniel J. Goldstein, MD; John D. Puskas, MD; John H. Alexander, MD; et al.
free access
JAMA Cardiol. 2022;7(8):808-816. doi:10.1001/jamacardio.2022.1437
This randomized clinical trial investigates the efficacy and safety of an external saphenous vein graft support device by determining the progression of intimal hyperplasia in patients undergoing a coronary bypass graft procedure.
Stuart Ennis, PhD; Grace Lobley, MSc; Sandra Worrall, BSc; et al.
free access
JAMA Cardiol. 2022;7(8):817-824. doi:10.1001/jamacardio.2022.1651
This randomized clinical trial investigates if starting cardiac rehabilitation exercise training 2 weeks after sternotomy is as effective and safe as starting 6 weeks after sternotomy in cardiac surgery patients.
Sripal Bangalore, MD, MHA; Judith S. Hochman, MD; Susanna R. Stevens, MS; et al.
free access
JAMA Cardiol. 2022;7(8):825-835. doi:10.1001/jamacardio.2022.1763
This secondary analysis of a randomized clinical trial evaluates clinical and quality-of-life outcomes following invasive and conservative management of chronic kidney disease.
Martin Bødtker Mortensen, MD, PhD; Anne Tybjærg-Hansen, MD, DMSc; Børge G. Nordestgaard, MD, DMSc
free access
JAMA Cardiol. 2022;7(8):836-843. doi:10.1001/jamacardio.2022.1876
This cohort study examines data from the Copenhagen General Population Study to compare the clinical performance of the 2021 European Society of Cardiology guidelines about statin use with guidelines from the American College of Cardiology/American Heart Association, UK National Institute for Health and Care Excellence, and previous European guidelines.
-
Editorial
Time to Revisit Using 10-Year Risk to Guide Statin Therapy
Ann Marie Navar, MD, PhD; Gregg C. Fonarow, MD; Michael J. Pencina, PhD
JAMA Cardiol
Matthew W. Segar, MD, MS; Jennifer L. Hall, PhD; Pardeep S. Jhund, MBChB, MSc, PhD; et al.
free access
has audio
JAMA Cardiol. 2022;7(8):844-854. doi:10.1001/jamacardio.2022.1900
This cohort study develops and validates a machine learning鈥揵ased model incorporating social determinants of health (SDOH) for predicting heart failure mortality.
-
Podcast:
Machine Learning鈥揃ased Models Incorporating SDOH vs Traditional Models for Predicting In-Hospital Mortality For Heart Failure
-
Invited Commentary
Machine Learning and Social Determinants of Health鈥擜n Opportunity to Move Beyond Race for Inpatient Risk Prediction in Patients With Heart Failure
Eldrin F. Lewis, MD, MPH
JAMA Cardiol
-
Podcast:
Machine Learning鈥揃ased Models Incorporating SDOH vs Traditional Models for Predicting In-Hospital Mortality For Heart Failure
-
Editor's Note
Replacing Race With Social Determinants of Health in Risk Prediction鈥擥etting It Right
Clyde W. Yancy, MD, MSc; Sadiya S. Khan, MD, MSc
JAMA Cardiol
Behnood Bikdeli, MD, MS; César Caraballo, MD; Javier Trujillo-Santos, MD, PhD; et al.
free access
JAMA Cardiol. 2022;7(8):857-865. doi:10.1001/jamacardio.2022.1988
This cohort study investigates the outcomes and clinical characteristics of patients with isolated distal deep vein thrombosis compared with those with proximal deep vein thrombosis.